HomeBREAKING NEWS Covaxin’s Phase 3 Trial Data Looks Good, Says Chief Scientist As Bharat Biotech Awaits WHO Approval July 8, 2021 Share Facebook Twitter Pinterest WhatsApp The overall efficacy is quite high. The vaccine efficacy against the Delta variant is low but it is still quite good, said Dr Soumya Swaminathan. Previous articleHC Seeks Stand of Delhi Govt, Centre on Allegation of Wastage of Food Grains Under CM SchemeNext articleIllegal Herb Smuggling Racket Busted In MP’s Sheopur Similar Articles Lakhimpur Kheri: Viral Video Shows Farmers Being Run Over by SUV, Oppn Questions Union Minister’s Claims BREAKING NEWS - October 5, 2021 The 29-second clip, which also shows another vehicle following the SUV, has raised questions on the version of the incident by Union minister Ajay... Karnataka: 3 Dead After Drinking Contaminated Water, 108 Show Similar Symptoms BREAKING NEWS - October 5, 2021 A total of six people have died in the last five weeks but the authorities have been able link just three of the deaths... Most Popular AMPC reforms: BJP digs out Siddaramaiah’s old letter India UAE Grow Bilateral Trade Amidst Worldwide Geopolitical Shifts Author Amish on why Bollywood doesn’t adapt ancient Sanskritic texts into films